Tyra Biosciences, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TYRA Nasdaq 2830 tyra.bio

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tyra Biosciences, Inc.

Is Tyra Biosciences, Inc. (TYRA) Stock a Biotech Opportunity Ahead of Key SURF302 Trial Data? - Jun 30th, 2026 7:07 am
Non-muscle Invasive Bladder Cancer Market Dynamics to Shift During the Forecast Period (2026-2036) as Novel Targeted and Gene Therapies Enter Late-Stage Development | DelveInsight - Jun 23rd, 2026 8:31 am
Is Tyra Biosciences (TYRA) Too Reliant On Dabogratinib Amid Renewed SURF-302 Skepticism? - Jun 11th, 2026 7:16 pm
Tyra Biosciences' Weak Investor Sentiment Reflects Macro Pressures, Renewed SURF-302 Concerns, BofA Says - Jun 10th, 2026 8:57 am
Wolfe Research Initiates Peer Perform rating on Tyra Biosciences, Inc. (TYRA) - Jun 1st, 2026 2:03 am
TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY - May 21st, 2026 6:00 am
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares - May 17th, 2026 1:01 pm
Assessing Tyra Biosciences (TYRA) Valuation After Strong One Year Share Price Momentum - May 14th, 2026 7:20 am
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights - May 13th, 2026 6:00 am
Tyra Biosciences to Participate in Upcoming Investor Conferences - May 7th, 2026 2:05 pm
Guggenheim Starts Tyra Biosciences, Inc. (TYRA) at Buy on Strength of Lead Drug Dabogratinib - Apr 24th, 2026 7:42 am
Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors - Apr 17th, 2026 6:00 am
A Look At Tyra Biosciences (TYRA) Valuation After $126 Million Stock Sale And Late Stage Trial Progress - Apr 4th, 2026 4:09 am
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position - Mar 20th, 2026 10:21 am
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - Mar 19th, 2026 1:23 pm
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit - Mar 18th, 2026 12:08 pm
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit - Mar 18th, 2026 11:54 am
Did Deeper Losses and Dabogratinib Progress Just Shift Tyra Biosciences' (TYRA) Investment Narrative? - Mar 3rd, 2026 7:10 pm
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - Mar 2nd, 2026 2:05 pm
Tyra Biosciences Narrows Dabogratinib Focus, Teases Mid-Year NMIBC and 2H Achondroplasia Data - Mar 2nd, 2026 12:11 am